MATERION Corp (MTRN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q4 '21: 388M Q4 '21: 397.2M Q2 '22: 449M Q3 '22: 445.3M Q3 '22: 428.2M Q4 '22: 434.6M Q1 '23: 442.5M Q2 '23: 398.6M Q3 '23: 403.1M Q4 '23: 421M Q1 '24: 385.3M Q2 '24: 425.9M Q3 '24: 436.7M Q4 '24: 436.9M Q1 '25: 420.3M Q2 '25: 431.7M Q3 '25: 444.8M Q4 '25: 489.8M Q2 '26: 549.8M Q3 '26: 613.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Gross Profit Quarterly

0 40M 80M 120M Q4 '21: 74.3M Q4 '21: 73.1M Q2 '22: 75.3M Q3 '22: 87.4M Q3 '22: 82.7M Q4 '22: 98.4M Q1 '23: 91.3M Q2 '23: 89.1M Q3 '23: 88.9M Q4 '23: 79.7M Q1 '24: 71.2M Q2 '24: 80.9M Q3 '24: 80.9M Q4 '24: 93M Q1 '25: 76.2M Q2 '25: 82.7M Q3 '25: 86.1M Q4 '25: 63.7M Q2 '26: 81.8M Q3 '26: 104.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Operating Income Quarterly

0 20M 40M 60M Q3 '21: 20.7M Q4 '21: 21.2M Q4 '21: 15.5M Q2 '22: 19.6M Q3 '22: 31.9M Q3 '22: 29.1M Q4 '22: 39.2M Q1 '23: 36.9M Q2 '23: 35.3M Q3 '23: 36.5M Q4 '23: 27.6M Q1 '24: 22.2M Q2 '24: 32.1M Q3 '24: 31.3M Q1 '25: 27.2M Q2 '25: 36.8M Q3 '25: 34.9M Q4 '25: 10.8M Q2 '26: 28.2M Q3 '26: 51.7M Q4 '21 Q3 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q3 '26

Net Income Quarterly

0 15M 30M 45M Q3 '21: 17.9M Q4 '21: 18.2M Q4 '21: 19.7M Q2 '22: 14M Q3 '22: 23.3M Q3 '22: 20M Q4 '22: 28.8M Q1 '23: 25.6M Q2 '23: 24.1M Q3 '23: 26.6M Q4 '23: 19.5M Q1 '24: 13.4M Q2 '24: 19M Q3 '24: 22.3M Q1 '25: 17.7M Q2 '25: 25.1M Q3 '25: 25.4M Q4 '25: 6.6M Q2 '26: 19.4M Q3 '26: 38.8M Q4 '21 Q3 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q3 '26

Cost of Revenue Quarterly

0 200M 400M 600M Q4 '21: 313.7M Q4 '21: 324.2M Q2 '22: 373.8M Q3 '22: 357.9M Q3 '22: 345.4M Q4 '22: 336.2M Q1 '23: 351.2M Q2 '23: 309.5M Q3 '23: 314.1M Q4 '23: 341.3M Q1 '24: 314.1M Q2 '24: 345M Q3 '24: 355.8M Q4 '24: 343.9M Q1 '25: 344.2M Q2 '25: 349M Q3 '25: 358.7M Q4 '25: 426.1M Q2 '26: 468M Q3 '26: 509.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Operating Cash Flow Quarterly

-30M 0 30M 60M 90M Q4 '21: -3.5M Q4 '21: 49.7M Q2 '22: -14.3M Q3 '22: 35.7M Q3 '22: 12.8M Q4 '22: 81.8M Q1 '23: 38.1M Q2 '23: 32.4M Q3 '23: 14M Q4 '23: 59.9M Q1 '24: -13.8M Q2 '24: 20.3M Q3 '24: 5.1M Q4 '24: 76.3M Q1 '25: 15.5M Q2 '25: 49.9M Q3 '25: 18.3M Q4 '25: 19.5M Q2 '26: -4.3M Q3 '26: 74.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Free Cash Flow Quarterly

-40M -20M 0 20M 40M 60M Q4 '20: 624K Q2 '21: -15.8M Q3 '21: 2.2M Q4 '21: -23.5M Q4 '21: 24.5M Q2 '22: -33.3M Q3 '22: 17M Q3 '22: -3.7M Q4 '22: 58.4M Q1 '23: 8.1M Q4 '23: 34.6M Q1 '24: -35.1M Q2 '24: 3.2M Q3 '24: -7.2M Q4 '24: 58.3M Q1 '25: 3.2M Q2 '25: 37.3M Q3 '25: 4.5M Q4 '25: 5M Q2 '26: -19.6M Q2 '21 Q4 '21 Q3 '22 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q1 '20: 20.4M Q2 '20: 20.6M Q3 '20: 20.6M Q2 '21: 20.6M Q3 '21: 20.7M Q4 '21: 20.7M Q2 '22: 20.7M Q3 '22: 20.7M Q3 '22: 20.8M Q1 '23: 20.9M Q2 '23: 20.9M Q3 '23: 20.9M Q1 '24: 21M Q2 '24: 20.9M Q3 '24: 20.9M Q1 '25: 20.9M Q2 '25: 20.8M Q3 '25: 20.9M Q2 '26: 21M Q3 '26: 21.1M Q2 '20 Q3 '21 Q3 '22 Q2 '23 Q2 '24 Q2 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q3 '20: 1.05 Q4 '20: 0.75 Q2 '21: 1.75 Q3 '21: 2.34 Q4 '21: 2.95 Q4 '21: 3.50 Q2 '22: 3.37 Q3 '22: 3.62 Q3 '22: 3.70 Q4 '22: 4.14 Q1 '23: 4.69 Q2 '23: 4.72 Q3 '23: 5.03 Q4 '23: 4.58 Q1 '24: 3.99 Q2 '24: 3.75 Q3 '24: 3.55 Q4 '25: 3.59 Q2 '26: 3.66 Q3 '26: 4.29 Q4 '20 Q4 '21 Q3 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.